Viridian Therapeutics, Inc.\DE (VRDN) Asset Writedowns and Impairment (2014)
Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Asset Writedowns and Impairment came in at $32508.0 in Q4 2014.
Viridian Therapeutics, Inc.\DE (VRDN) Asset Writedowns and Impairment (2014) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $32508.0 for Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 655.26 Mn | 655.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 32,508.00 |
| Dec 31, 2014 | 32,508.00 |